Business Daily Media

Merck Announces Emerging Biotech Grant Program Winners

  • Award recipients to receive in-kind technologies and services to accelerate therapeutics to market
  • Merck experts to provide consultation and training in qualification, risk assessment, and process optimization
  • Program extended this year to Australia, New Zealand, Taiwan, South Korea

SINGAPORE - Media OutReach Newswire - 1 November 2024 - Merck, a leading science and technology company, today announced the winners of its Emerging Biotech (EB) Grant Program in Asia Pacific.

The Award is designed to support biotech startups with resources to enable emerging companies to discover, develop, optimize, and commercialize therapeutics faster and more efficiently.

Merck Emerging Biotech Award Recipients for Taiwan receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Taiwan receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Australia receiving their awards at the award ceremony.
Merck Emerging Biotech Award Recipients for Australia receiving their awards at the award ceremony.



"Merck is committed to supporting exceptional biotech companies to both kickstart and streamline their journey from discovery to manufacturing with our grant program," said Chua Keng Hock, Senior Vice President, Process Solutions Asia Pacific, Life Science business of Merck. "We recognize the complexities involved in delivering next-generation therapies to the market. Merck's EB Grant is designed to expedite the development of treatments that address critical unmet medical needs."

The award recipients are:

Country
Grand Prize Winner
Finalist Prize Winners
Special Mention
Australia & New Zealand
Southern RNA for enabling the manufacturing of mRNA for personalized medicines
Institute for Drug Technology for enabling the manufacturing of antibody-drug conjugates.

Psaio for developing bispecific antibodies targeting prostate-specific antigen to treat prostate cancer.
Kimer Med for developing

a family of broad-spectrum antiviral biologics to treat infectious diseases, and for pandemic protection.
Taiwan
HanchorBio for developing clinical-stage and next-generation immuno-oncology therapies through innovation in cutting-edge designer biologics with novel, multi-functional modalities.
Pell Biomed Technology for developing more efficient and cost-effective gene-modified cell therapies.

Glyconex for glycan-directed cancer therapies including antibody-drug conjugates to treat a range of solid tumors such as gastrointestinal cancers.
Shine-On BioMedical for developing targeted exosomes as a platform for drug delivery as well as tri-specific antibody for cancer treatment.

Merck experts selected the winning submissions based on the scientific and societal merit of the therapy in development and process challenges and expertise gaps that may impact ongoing development. In-kind technologies and services from Merck will be awarded to the winners in Australia & New Zealand and Taiwan to help solve these challenges.

Merck first started the EB grant program in 2014 in the United States and has expanded its reach to include Europe, China, South Korea and Taiwan in recent years. In 2024, the EB Grant was extended to Australia & New Zealand and is open to Taiwan and South Korea (the winners for South Korea were announced in July 2024). To-date, Merck's EB Grant program has awarded technologies and consultation to over 40 biotechnology companies around the world, supporting their efforts to improve patient outcomes for various diseases such as cancer, brain tumors, osteoarthritis, and cardiovascular disorders.

https://www.sigmaaldrich.com/SG/en/applications/pharmaceutical-and-biopharmaceutical-manufacturing/biotech-resource-hub/startup-programs#our-grant-programs

Other Merck grants at group level:
https://www.merckgroup.com/en/research/open-innovation.html

Hashtag: #Merck

The issuer is solely responsible for the content of this announcement.

About Merck

Merck, a leading science and technology company, operates across life science, healthcare and electronics. Around 63,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2023, Merck generated sales of € 21 billion in 65 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.

All Merck press releases are distributed by e-mail at the same time they become available on the Merck website. Please go to to register online, change your selection or discontinue this service.

News from Asia

Madar Saudi Arabia Recognized as One of the Best Places to Work for 2024

RIYADH, SAUDI ARABIA - Media OutReach Newswire - 31 October 2024 - Madar is proud to announce its certification as a Best Places to Work for 2024, a recognition that highlights the company's unwav...

AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license

Application for drug marketing registration duly submitted Super heavyweight items are expected to drive performance soaring HONG KONG SAR - Media OutReach Newswire – 1 November 2024 - AIM Vaccin...

Light Show Illuminates the Liangma River

BEIJING, CHINA - Media OutReach Newswire - 31 October 2024 - During the recently launched 2024 Beijing Chaoyang International Light Festival, the Liangma River Cultural and Economic Belt, on the t...

426 Major Projects Accelerating in Ordos

ORDOS, CHINA – Media OutReach Newswire – 31 October 2024 - On October 28, nearly 20,000 builders fought on the front line at the site of the 2.6 million tons of coal-to-olefins and supporting 400...

VTEX and ChannelEngine Forge Powerful Alliance to Revolutionize the Ecommerce Landscape

SINGAPORE - Media OutReach Newswire - 4 March 2024 - VTEX (NYSE: VTEX), the global enterprise digital commerce platform, announced today its partnership with ChannelEngine, a leading global marke...

Siam Paragon Bangkok International Fashion Week 2024 Unveils the best of Thai and Asian Creativity And Reaffirms Siam Paragon As the Number One ‘Luxury Destination’

BANGKOK, THAILAND - Media OutReach Newswire - 1 November 2024 - Siam Paragon reaffirms its positioning as a leading 'global luxury destination' and the top-of-mind destination for both Thai and i...

EdgeProp announces winners of EdgeProp Excellence Awards 2024; City Developments, GuocoLand, SingHaiyi Group and UOL Group are Top Developers

City Developments, GuocoLand, SingHaiyi Group and UOL Group emerged as major winners with more than 9 awards each Lentor Mansion, Tembusu Grand and TMW Maxwell clinched 4 Exc...

Merck Announces Emerging Biotech Grant Program Winners

Award recipients to receive in-kind technologies and services to accelerate therapeutics to market Merck experts to provide consultation and training in qualification, risk assess...

Ocean City to host International Lantern Design Contest and Festival

HANOI, VIETNAM- Media OutReach Newswire - 1 November 2024 - Vinhomes JSC and Sunny Vietnam Co. announce the launch of the Ocean International Lantern Contest and Festival. This event marks the fi...

Lee Kum Kee Garners Industry Cares Recognition Scheme 2024 ‘Grand Award’ from the Federation of Hong Kong Industries

HONG KONG SAR - Media OutReach Newswire - 1 November 2024 - On 26 September, Lee Kum Kee rejoiced as the recipient of the esteemed 'Grand Award', 'The Most Devoted Award' and 'The Most Innovative ...

Liked and shared: How social media can elevate your customer experience

Don’t neglect this golden opportunity to connect with customers and win mind and market share. Is social media central to your business developme...

Business Training

The 5 Tell-Tale Signs Of a Toxic Workplace

Wearing a mask wears you out. Faking it is fatiguing. The most exhausting activity is pretending to be what you know you aren’t. – Rick Warren ...

Business Training

6 reasons why real estate is the safest long-term investment

An astonishing fact is that ninety percent of millionaires are getting rich by investing in Real Estate. Real estate provides the most reliable pl...

Property

Which stocks should you be monitoring in 2021, and how do you keep tabs on them

Every few years or so, the stock market enters a new cycle of bullishness and promise. Whether it’s the tech companies that broke out of the do...

Business Training

5 Stages of Construction That Will Transform Your Vacant Land into a New Home

If you're thinking about building a home or want to learn more about the process, there are several stages of construction that you should be awar...

Property

How to Build Business Credit Fast Using Net 30 Accounts

Building strong business credit is like building a skyscraper-it takes a solid foundation and careful construction. Unlike a skyscraper, however, ...

Business Training